A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins

13.5K views

⸱

DOI:

10.3791/56766

⸱

June 12th, 2018

 ,  ,  , 

In This Article

Summary

This manuscript details a straightforward dot blot assay for quantitation of adeno-associated virus (AAV) titers and its application to study the role of assembly-activating proteins (AAPs), a novel class of non-structural viral proteins found in all AAV serotypes, in promoting the assembly of capsids derived from cognate and heterologous AAV serotypes.

Abstract

While adeno-associated virus (AAV) is widely accepted as an attractive vector for gene therapy, it also serves as a model virus for understanding virus biology. In the latter respect, the recent discovery of a non-structural AAV protein, termed assembly-activating protein (AAP), has shed new light on the processes involved in assembly of the viral capsid VP proteins into a capsid. Although many AAV serotypes require AAP for assembly, we have recently reported that AAV4, 5, and 11 are exceptions to this rule. Furthermore, we demonstrated that AAPs and assembled capsids of different serotypes localize to different subcellular compartments. This unexpected heterogeneity in the biological properties and functional roles of AAPs among different AAV serotypes underscores the importance of studies on AAPs derived from diverse serotypes. This manuscript details a straightforward dot blot assay for AAV quantitation and its application to assess AAP dependency and serotype specificity in capsid assembly. To demonstrate the utility of this dot blot assay, we set out to characterize capsid assembly and AAP dependency of Snake AAV, a previously uncharacterized reptile AAV, as well as AAV5 and AAV9, which have previously been shown to be AAP-independent and AAP-dependent serotypes, respectively. The assay revealed that Snake AAV capsid assembly requires Snake AAP and cannot be promoted by AAPs from AAV5 and AAV9. The assay also showed that, unlike many of the common serotype AAPs that promote heterologous capsid assembly by cross-complementation, Snake AAP does not promote assembly of AAV9 capsids. In addition, we show that the choice of nuclease significantly affects the readout of the dot blot assay, and thus, choosing an optimal enzyme is critical for successful assessment of AAV titers.

Introduction

Adeno-associated virus (AAV) is a small, non-enveloped, single-stranded DNA virus with a genome of approximately 4.7 kilobases (kb). The AAV genome contains open-reading frames (ORFs) for the rep and cap genes. In 2010, a previously unidentified nonstructural protein encoded by a +1 frame-shifted ORF within the AAV2 cap gene was discovered by Sonntag et al. and found to play a critical role in the assembly of AAV2 capsid VP monomer proteins into a viral capsid1. This novel protein has been named assembly-activating protein (AAP) after the role it plays in promoting capsid assembly1.

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: Recipes for the solutions and buffers needed for this protocol are provided in Table 1. The protocol described below is for the VP-AAP cross-complementation dot blot assay to study the roles of the AAP proteins in capsid assembly. The method for the more generic quantitative dot blot assay for purified AAV vector titration is explained in the Representative Results section.

1. Construction of VP3, AAP, and AAV2 Rep Expressing Plasmids

  1. Construction of pCMV-AAVx-VP3 (x = serotypes)
    1. PCR-amplify the entire VP3 ORF (1.6 kb) using a high-fidelity DNA polymerase and t....

Access restricted. Please log in or start a trial to view this content.

Results

A representative result of quantitative dot blots for quantitation of purified AAV vector stocks produced on a large scale is shown in Figure 1. With this dot blot assay, the titer of a double-stranded AAV2G9-CMV-GFP vector stock was determined. The vector was purified by two rounds of cesium chloride (CsCl) density-gradient ultracentrifugation followed by dialysis as previously described20. In general, for purified AAV vector stocks, .......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this report, the utility of quantitative dot blot assays to study AAV AAPs and their role in capsid assembly is described. Knowledge gained from these studies can provide detailed insights into the innate differences in the process of AAV capsid assembly and the functional role of AAPs between different serotypes. In this respect, the AAV VP3-AAP cross-complementation dot blot assay revealed that Snake AAV VP3 displayed a strict dependency on the co-expression of its cognate AAP for capsid assembly and that Snake AAP .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Xiao Xiao at the University of North Carolina at Chapel Hill for providing us with the pEMBL-CMV-GFP plasmid. We thank Christopher Cheng and Samuel J. Huang for critical reading of the manuscript. This work was supported by Public Health Service grants (NIH R01 NS088399 and T32 EY232113).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BenzonaseMilliporeSigma1016970001Referred to as Serratia marcescen endonuclease in the main text.
DNase IRoche4716728001Referred to as DNase I Enzyme A in the main text.
DNase IInvitrogen18047019Referred to as DNase I Enzyme B in the main text.
DNase INew England BiolabsM0303LReferred to as DNase I Enzyme C in the main text.
1.5 mL Attached O-Ring Screw Cap Microcentrifuge TubesCorning430909
1.5 mL Microcentrifuge TubesThermo Fisher Scientific05-408-129
15 mL Polypropylene Conical TubeCorning352097
3 M Sodium AcetateTeknovaS0298
50 mL Polypropylene Conical TubeCorning430291
AAV-293 CellsAgilent240073HEK-293 cell line optimized for the packaging of AAV virions.
AccuGENE 0.5 M EDTA SolutionLonza51234
AccuGENE 1 M Tris-HCl pH 8.0Lonza51238
AccuGENE 10% SDSLonza51213
AccuGENE 1X TE BufferLonza51235
Bio-Dot ApparatusBio-Rad1706545
Bovine Serum AlbuminMilliporeSigmaA3294
Cell LifterCorning3008
ChloroformMilliporeSigma372978
DNA Extractor KitWako Pure Chemical Industries295-50201This is used for quantitative dot blots on purified virus. We use only a half volume of all the reagents in each step recommended for the Protocol Scheme 2 in the manual provided by the manufacturer.
Dulbecco’s Modified Eagle Medium (DMEM)-high glucose (4.5 g/L)Lonza12-614F
ElectroMAX DH10B CellsThermo Fisher Scientific18290015
Ethanol 200 ProofDecon Labs2716
Fetal Bovine SerumVWR1500-500
Ficoll 400Alfa AesarB22095Referred to as Polysucrose 400.
Fluorescence MicroscopeZeissAxiovert 40 CFL
GlycogenRoche10901393001
Herring Sperm DNAInvitrogen15634-017
Hybridization TubesThermo Fisher Scientific13-247-150
ImageQuant TLGE Healthcare Life SciencesImageQuant TL
L-glutamine 200 mMLonza17-605E
Magnesium Chloride HexahydrateMilliporeSigmaM0250
MicroPulser ElectroporatorBio-Rad1652100
Mini Quick Spin DNA ColumnsMilliporeSigma11814419001
pAAV-RC2 VectorCell Biolabs IncVPK-422
Penicillin/Streptomycin 10K/10KLonza17-602E
Phosphate Buffered SalineLonza17-516F
Phosphorimaging Exposure CassetteGE Healthcare Life SciencesVarious
Phosphorimaging ScreenGE Healthcare Life SciencesVarious
Plasmid Maxi KitQIAGEN12162
Platinum Pfx DNA PolymeraseInvitrogen11708013
PolyethyleniminePolysciences Inc23966-2
PolyvinylpyrrolidoneMilliporeSigmaP5288
Prime-It II Random Primer Labeling KitAgilent Technologies300385
Primer AAP Forward (N25 nucleotides from the 4th nucleotide in the AAP ORF, RE1 is a restriction enzyme site for cloning): CTAA-RE1-CACCATGGACTACAAGGA
CGACGATGACAAA-N25
MilliporeSigmaCustom Primer
Primer AAP Reverse (N25 is the last 25 nucleotides of the AAP ORF, RE2 is a restriction enzyme site for cloning): TCTT-RE2-N25MilliporeSigmaCustom Primer
Primer VP3 Forward (N25 the first 25 nucleotides of the VP3 ORF, RE1 is a restriction enzyme site for cloning): CTAA-RE1-CACC-N25MilliporeSigmaCustom Primer
Primer VP3 Reverse (N25 is the last 25 nucleotides of the AAP ORF, RE2 is a restriction enzyme site for cloning): TCTT-RE2-N25MilliporeSigmaCustom Primer
Proteinase K SolutionInvitrogen25530-049
Restriction EnzymesNew England BiolabsVarious
Salmon Sperm DNAInvitrogen15632011
Serological PipettesThermo Fisher Scientific13-678-11D / 13-678-11E / 13-678-11
Sodium ChlorideThermo Fisher ScientificS271-10
Sodium Citrate Tribasic DihydrateMilliporeSigmaC8532
T4 DNA PolymeraseNew England BiolabsM0203L
Thermal CyclerEppendorf6321000515
Tissue-culture Treated 6-well PlateCorning353046
Tris BaseThermo Fisher ScientificBP152-5
Typhoon FLA 7000GE Healthcare Life Sciences28955809
UltraPure Buffer-Saturated PhenolInvitrogen15513-047
UV CrosslinkerSpectrolineXLE-1000Optimal Crosslink mode is used, providing a UV energy dosage of 120 mJ/cm2.
Zeta-Probe MembraneBio-Rad162-0165

References

  1. Sonntag, F., Schmidt, K., Kleinschmidt, J. A. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci U S A. 107 (22), 10220-10225 (2010).
  2. Sonntag, F., et al. The assembly-activating protein p....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Assembly-activating ProteinCapsid AssemblyAAV QuantitationNuclease TreatmentViral Particle RecoveryPlasmid DNA StandardsHybridization BufferGeiger Counter Detection